Skip to main content

Table 2 General features of the studies which were included

From: Adverse drug effects observed with vildagliptin versus pioglitazone or rosiglitazone in the treatment of patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials

Studies

Type of study

No of patients treated with vildagliptin (n)

No of patients treated by pioglitazone or rosiglitazone (n)

Drug used in experimental/control groups

Bolli2008 [7]

RCT

295

280

Pioglitazone/vildagliptin

Garber2006 [8]

RCT

304

158

Pioglitazone/vildagliptin

Kim2010 [9]

RCT

35

36

Pioglitazone/vildagliptin

Rosenstock2007 [10]

RCT

459

238

Rosiglitazone/vildagliptin

Rosenstock2009 [11]

RCT

393

198

Rosiglitazone/vildagliptin

Total no of patients (n)

 

1486

910

 
  1. Abbreviations: RCT randomized controlled trials